Ophthalmic lasers allow precise treatment of a range of eye problems with little risk of infection. Numerous laser procedures are generally pain free and can be performed on an outpatient basis. The combination of safety, accuracy, and relative low cost make lasers very useful ophthalmic tools. The main components of a laser system are the laser console, the foot pedal, and the laser delivery system. Different types of lasers emit specific wavelengths of light and are used to treat specific eye problems. The effects that lasers have on eye tissues are both a function of the molecular composition of the tissue and of the wavelength and power of the laser light. Lasers essentially destroy tissue in order to have a beneficial effect on the eye.
The ophthalmic laser market is likely to grow over the forecast period, due to factors such as demographic shift, the increasing of the prevalence of eye disease, technological advancements in the field of in ophthalmic laser, and increasing ageing populace. The aging population is expected to burden all areas of health care, and ophthalmologists provide approximately 90% of their procedure-based services to seniors
The report analyses the global ophthalmic lasers market based on type, application, end user and geography
The various types of ophthalmic lasers are commercially available in the market including femtosecond lasers, excimer lasers, Nd:YAG lasers, SLT laser, diode lasers etc. The Nd:YAG laser is a solid state laser that uses a neodymium-doped yttrium-aluminum-garnet crystal as the lasing medium. It is optically pumped with a lamp or diode and most commonly emits infrared light at 1064nm. It can be used in either a pulsed or continuous mode. Pulsed YAG lasers are typically Q-switched to achieve high-intensity pulses, which can be doubled to emit light at 532nm. This type of laser is used in various application including treatment of posterior capsular opacification after cataract surgery and to create a peripheral iridotomy in patients with narrow angles or angle-closure glaucoma. The popularity Nd:YAG lasers is attributed to diverse applications of these lasers in the treatment of various eye diseases.
Ophthalmic lasers find application in cataracts, glaucoma, diabetic retinopathy, macular degeneration (AMD), refractive corrections etc. The prevalence of visual impairment-related diseases is increasing globally, owing to change in lifestyle, such as smoking tobacco. Ophthalmic lasers provide a viable alternative for treatment of eye-related diseases, such as glaucoma, cataract, refractive error, age-related macular degeneration, and diabetic retinopathy.
The major end user for ophthalmic laser products are hospitals, clinics and ambulatory service centers
North America, Europe, Asia Pacific and Rest of the World are key regions covered for the global ophthalmic laser market. Currently, North America holds the major chunk of market share and is expected to continue its stronghold for a few more years. On the other hand, Asia Pacific is anticipated to be the most important region that is expected to gain traction in terms of market revenue in coming year because of rise in number of ocular diseases in this region, growing economy, availability of expert services and local presence of key player. Further, Japan, Singapore, China, India, and South Korea are the key contributors in the Asia Pacific region.
The key companies which led this industry verticals include Carl Ziess Meditec Ag, Novartis AG, Topcon Corporation, Ellex Medical Corporation, Quantel Inc., Iridex Corporation, Nidek Co., LTD., Lumenis, Abbott Laboratories, Ziemer Ophthalmic Systems. Lightmed USA, Coherent, Inc., Ocular Instruments, Asico LLC., Deka M.E.L.A. S.r.l., NoIR Laser Company, LLC. and among others